Absolutely it helps prevent unnecessary fat gain
Labels typically recommend reducing insulin or sulfonylurea doses when starting GLP 1 therapy, with close glucose monitoring
Skip to content When autocomplete results are available use up and down arrows to review and enter to select
N Engl J Med 381(9): 841 851 Fudim M, White J, Pagidipati NJ, Lokhnygina Y, Wainstein J, Murin J, Iqbal N, hman P, Lopes RD, Reicher B, Holman RR, Hernandez AF, Mentz RJ (2019) Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes Mellitus With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial